Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago
80 mg
5 x 10
৳3.00

Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.

All price changes →

Save on this medicine

Same active ingredient — pay up to 25% less

These brands contain the same active ingredient (Verapamil Hydrochloride). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.

From ৳3.00 (5 x 10)
Available as: 80 mg · 5 x 10

Indications & Uses

Veracal is indicated for:

Dosage Reference

Reference Information Only

Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.

Adults:

Verapamil Tablet: The dose of Verapamil should be individualized by titration, and the drug should be taken with food. For essential hypertension, the initial dose is 180 mg in the morning. If an adequate response is not obtained with 180 mg of Verapamil, the dose may be titrated in the following manner: 240 mg each morning; 180 mg each morning plus 180 mg each evening; or 240 mg every 12 hours. For angina, the usual dose is 80 mg to 120 mg three times a day. For arrhythmias in digitalized patients, Verapamil should be given at 240 mg to 360 mg in divided doses, depending on the severity of the condition. Divided doses of up to 180 mg a day may occasionally be needed. Verapamil Injection: Adults: 5 mg slowly by intravenous injection for tachycardias and hypertensive crises, repeated after 5 to 10 minutes if necessary. As a drip infusion to maintain the therapeutic effect, 5 to 10 mg an hour in physiological saline, glucose, laevulose or similar solutions, up to an average total dose of 100 mg a day. Children: newborns, 0.75 to 1 mg (0.3 to 0.4 ml); infants, 0.75 to 2 mg (0.3 to 0.8 ml); children aged 1 to 5 years, 2 to 3 mg (0.8 to 1.2 ml); and children aged 6 to 14 years, 2.5 to 5 mg (1 to 2 ml) of Verapamil, given intravenously depending on age and response. The injection should be given slowly under electrocardiographic control and only until the effect begins. For intravenous infusion in hypertensive crises, the initial dose is 0.05 to 0.1 mg/kg an hour; if the effect proves insufficient, the dose is increased at 30 to 60 minute intervals until twice the dose or more is reached, up to an average total dose of 1.5 mg/kg a day.

Side Effects

Veramil SR is generally well tolerated. The following reactions to orally administered Veramil SR appeared clearly drug-related or occurred at rates greater than 1% in clinical trials involving approximately 5000 patients. Digestive system: constipation, nausea. Cardiovascular system: hypotension, edema, congestive heart failure (CHF), pulmonary edema, bradycardia, AV block. Respiratory system: upper respiratory tract infections. Nervous system: dizziness, headache, fatigue. Skin: rash, flushing. Hepatic: elevated liver enzymes.

Cautions & Contraindications

Warnings & Precautions

Care should be taken in 1st degree AV block, bradycardia <50 beats/minutes, hypotension <90 mm Hg systolic pressure, atrial fibrillation/flutter and simultaneous pre-excitation syndrome e.g. WPW syndrome, heart failure (previous compensation with cardiac glycosides/diuretics required). Veramil SR may impair ability to drive or operate machinery, particularly in the initial stages of treatment and with concomitant consumption of alcohol. Veramil SR markedly slows down the elimination of alcohol and prolongs the duration of the effects of alcohol.

Contraindications

Severe left ventricular dysfunction. Hypotension or cardiogenic shock. Sick sinus syndrome, unless the patient has a functioning artificial ventricular pacemaker. Second- or third-degree atrioventricular (AV) block, unless the patient has a functioning artificial pacemaker. Atrial flutter or atrial fibrillation in patients with an accessory bypass tract (e.g., Wolff-Parkinson-White or Lown-Ganong-Levine syndrome). Known hypersensitivity to verapamil hydrochloride.

Drug Interactions

Open checker →
Last updated: 20 Aug 2026